HOUSTON ― The University of Texas MD Anderson Cancer Center, in collaboration with the AT&T Foundry for Connected Health, will launch Connect to End Cancer on Sunday, March 12, 2017 at the South by Southwest® Conference and Festivals (SXSW®) in Austin, Texas. The inaugural event will provide education, exposure and potential development support to entrepreneurs as well as encourage collaboration among innovators, industry executives...
Experts from The University of Texas MD Anderson Cancer Center return to Palm Beach Wednesday, Jan. 11 for the Making Cancer History® Seminar...
James and Miriam Mulva and the Mulva Family Foundation have donated $50 million to advance neuroscience at The University of Texas at Austin...
In the first study evaluating patient-reported cosmetic outcomes in a population-based cohort of older women with breast cancer, The University of Texas MD Anderson Cancer Center researchers found that less radiation was associated with improved cosmetic satisfaction long-term. However, reduced radiation was also associated with a slightly increased risk of disease recurrence.  ...
In a pilot study conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients...
The University of Texas MD Anderson Cancer Center fully supports the United States Surgeon General’s call to action to prevent the use of...
With strong bipartisan support, the U.S. House and Senate have passed transformative legislation, the 21st Century Cures Act, which will support...
Richard Gorlick, M.D., an internationally recognized expert in pediatric oncology and hematology, today joined The University of Texas MD...
The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival...
Patients who potentially could benefit most from participation in clinical trials due to poor prognoses often are not included based on eligibility...
Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after...